Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,235 public trials 3,234 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

NCT03516942

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +28 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 716 locations
View Trial Details
Active, Not Recruiting

Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)

NCT05782465

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Stanford University Stanford, California, United States
  • The Chinese University of Hong Kong Hong Kong
  • Nihon University School of Medicine Tokyo, Japan
  • National University Hospital Singapore
View Trial Details
Active, Not Recruiting

A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

NCT06168812

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +11 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05581004

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +57 more
Locations
  • Stanford University San Francisco, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

NCT07021066

Conditions
Adenocarcinoma Of Esophagus, Advanced Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer, +9 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of Colorado Health Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View Trial Details

Related conditions